(Q37972641)

26 August 2017

title

Iron deficiency syndromes and iron-restricted erythropoiesis (CME). (English)

1 reference

26 August 2017

1 reference

Lawrence Tim Goodnough

series ordinal

1

1 reference

26 August 2017

publication date

29 December 2011

1 reference

26 August 2017

1 reference

26 August 2017

volume

52

1 reference

26 August 2017

issue

7

1 reference

26 August 2017

page(s)

1584-1592

1 reference

Diagnosis of iron-deficiency anemia in the elderly

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Proinflammatory state, hepcidin, and anemia in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Iron-deficiency anaemia and delay in the diagnosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

What proportion of patients referred to secondary care with iron deficiency anemia have colon cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Detection, evaluation, and management of iron-restricted erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Intravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Control of marrow production by the level of iron supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Perspectives in iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Ferumoxytol for treating iron deficiency anemia in CKD

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

The effect of oral iron supplementation on erythropoiesis in autologous blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Hepcidin and iron regulation, 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

The role of hepcidin in iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Forging a field: the golden age of iron biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Iron-refractory iron deficiency anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Immunoassay for human serum hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Suppression of hepcidin during anemia requires erythropoietic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Iron Loading and Overloading due to Ineffective Erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

21 January 2018

Hepcidin for clinicians

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

The microcytic red cell and the anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Iron, infections, and anemia of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

Acute injury with intravenous iron and concerns regarding long-term safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2011.03495.X

10.1111/J.1537-2995.2011.03495.X

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference